References
- 1. Katz N. The impact of pain management on quality of life. J Pain Symptom Manage. 2002;24(1):S38–S47.10.1016/S0885-3924(02)00411-6
- 2. Kitzes JA, Domer T. Palliative Care. J Pain Palliat Care Pharmacother. 2004;17(3):201–10.10.1300/J354v17n03_30
- 3. Palat G, Venkateswaran C. Progress in palliative care in India. Progress in Palliative Care. 2012;20(4):212–8.10.1179/1743291X12Y.0000000022
- 4. Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84:587–93.10.1054/bjoc.2001.1680
- 5. Thirlwell MP, Sloan PA, Maroun J, Boos J, Besner JG, Stewart JH, et al. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients. Cancer. 1989;63(11):2275–83.10.1002/1097-0142(19890601)63:11<2275::AID-CNCR2820631136>3.0.CO;2-4
- 6. Rajagopal M R, Venkateswaran C. Palliative Care in India: Successes and Limitations. J Pain Palliat Care Pharmacother. 2003;17 (3):121–8.
- 7. Breivik H, Cherny N, Collet B, de Conno F, Filbert M, Foubert AJ, et al. Cancer - related pain: a pan-European survey of prevalence, treatment, and patient-attitudes. Ann Oncol. 2009;20(8):1420–33.10.1093/annonc/mdp001
- 8. Brown J, Setnik B, Lee K, Cleveland JM, Roland CL, Wase L, et al. Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting. J Pain Res. 2011;4:373–84.
- 9. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic non cancer pain. J Pain. 2009;10(2):113–30.10.1016/j.jpain.2008.10.008
- 10. Penning-van Beest F, van der Haak P, Klok RM, Prevoo YFDM, van der Peet D, Herings RMC. Quality of life in relation to constipation among opioid users. J Med Econ. 2010;13(1):129–35.10.3111/13696990903584436
- 11. Pappagallo M. Incidence, prevalence and management of opioid bowel dysfunction. Am J of Surg. 2001;182(5):s11–s18.10.1016/S0002-9610(01)00782-6
- 12. Elumelu T, Abdus Salam A, Soyanwoo O, Adenipekun A. Pattern of morphine prescription by doctors in a Nigeria tertiary hospital. Nigerian J Clin Pract. 2012;15(1):27–9.10.4103/1119-3077.94092
- 13. Barathi B. Oral morphine prescribing practices in severe cancer pain. Indian J Palliat Care. 2009;15 (2):127.10.4103/0973-1075.58458
- 14. Mercadante S, Berchovich M, Casuccio A, Fulfaro F, Mangione S. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care. 2007;24(1):13–9.10.1177/1049909106295431
- 15. Schug S, Sidebotham D, McGuinnety M, Thomas J, Fox L. Acetaminophen as an adjunct to morphine by patient-controlled analgesia in the management of acute postoperative pain. Anesth Analg. 1998;87(2):368–72.10.1213/00000539-199808000-00024
- 16. Breitbart W. Psychotropic adjuvant analgesics for pain in cancer and AIDS. Psycho-Oncology. 1998;7(4):333–45.10.1002/(SICI)1099-1611(199807/08)7:4<333::AID-PON365>3.0.CO;2-F
- 17. Watson CP.Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage. 1994;9(6):392–405.10.1016/0885-3924(94)90177-5
- 18. Reddy S, Patt RB. The benzodiazepines as adjuvant analgesics. J Pain Symptom Manage. 1994;9(8):510–4.10.1016/0885-3924(94)90112-0
- 19. Matoba M. Use of morphine and adjuvant drugs according to the condition. Eur J Pain. 2001;5(SA):59–62.10.1053/eujp.2001.0281
- 20. Patt RB, Proper G, Reddy S. The neuroleptics as adjuvant analgesics. J Pain Symptom Manage. 1994;9(7):446–53.10.1016/0885-3924(94)90201-1
- 21. Caraceni A, Zecca E, Martini C, de Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage. 1999;17(6):441–5.10.1016/S0885-3924(99)00033-0
- 22. Khan MI, Walsh D, Brito-DellanN.Opioid and adjuvant analgesics: compared and contract. Am J Hosp Palliat Care. 2011;28(5):378–83.10.1177/1049909111410298
- 23. Elliott TE, Elliott BA. Physician attitudes and beliefs about use of morphine for cancer pain. J Pain Symptom Manage. 1992;7(3):141–8.10.1016/S0885-3924(06)80005-9
- 24. Klepstad P, Rakvag T, Kaas S, Holthe M, Dale O, Borchgrevink PC, et al. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand. 2004; 48(10):1232–9.10.1111/j.1399-6576.2004.00517.x15504181
- 25. Tywcross R, Miller M. Palliative care. In: Oxford textbook of medicine 4e. Warrell DA, Cox TM, Firth JD (eds). Oxford: Oxford University Press; 2003:1397–407.
- 26. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19(9):2542–54.10.1200/JCO.2001.19.9.254211331334